Abstract 22q11. 2 deletion syndrome (22q11. 2DS) is the most common chromosomal
microdeletion disorder, estimated to result mainly from de novo non-homologous meiotic …

Objectives: The objectives of this review are to discuss the scope of neurologic injuries in
newborns with congenital heart disease, the mechanisms of injury, including prenatal, pre …

Objectives. Although several studies describe the 22q11. 2 deletion, population-based data
are scant. Such data are needed to evaluate properly the impact, distribution, and clinical …

Abstract Chromosome 22q11. 2 deletion syndrome is a common syndrome also known as
DiGeorge syndrome and velocardiofacial syndrome. It occurs in approximately 1: 4000 …

Recent studies are beginning to paint a clear and consistent picture of the impairments in
psychological and cognitive competencies that are associated with microdeletions in …

Velocardiofacial syndrome, DiGeorge syndrome, and some other clinical syndromes have in
common a high frequency of hemizygous deletions of chromosome 22q11. 2. This deletion …

22q11. 2 deletion syndrome (22q11. 2DS) is a disorder caused by recurrent, chromosome‐
specific, low copy repeat (LCR)–mediated copy‐number losses of chromosome 22q11. The …

DiGeorge syndrome, velocardiofacial syndrome and various other malformations have been
described in association with deletions and translocations involving human chromosome …

Abstract Purpose The chromosome 22q11. 2 deletion has been identified in the majority of
patients with DiGeorge syndrome, velocardiofacial syndrome, and conotruncal anomaly face …

The enzyme catechol-O-methyl transferase (COMT), identified in the 1950s, is involved in
catabolism of monoamines that are influenced by psychotropic medications, including …